Well if the consensus for Q1 is 268M$ and the earlier guidance for end 2015 run rate is >3B$/yr which comes to about 750M$/q by the end of 2015, then if abbvie sticks to that guidance, the growth rate will be pretty darned spectacular somewhere between now and the end of the yr , right ?
News 
Market Data 
Discover 
